India to South Africa: Hydrocortisone Export Trade Route

The India to South Africa Hydrocortisone corridor is one of India's established pharmaceutical export routes, with 95 shipments documented worth a combined $2.4M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's hydrocortisone manufacturing sector.

Across 13 active suppliers, the average shipment value stands at $25.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with hydrocortisone's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 14.6%, placing it at rank #4 among India's top hydrocortisone export destinations globally.

On the import side, key buyers of Indian hydrocortisone in South Africa include MACLEODS PHARMACEUTICALS SA, MACLEODS PHARMACEUTICALS SA, , MACLEODS PHARMACEUTICALS SA (PTY) and 19 others. MACLEODS PHARMACEUTICALS SA is the single largest importer with 30 shipments valued at $786.3K USD.

India's hydrocortisone exports to South Africa are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 37 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 13 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LTD , MACLEODS PHARMACEUTICALS LIMITED — together account for 87% of total trade value on this route. The average shipment value of $25.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as hydrocortisone sodium succinate injection 100 mg each vial containing hydrocortisone sodium succinate 134 mg equivalent and hydrocortisone sodium succinate injection 100 mg each vial containing hydrocortisone sodium succinate, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MACLEODS PHARMACEUTICALS SA is the largest importer with 30 shipments worth $786.3K USD — representing 32% of all hydrocortisone imports from India on this route. A total of 22 buyers are active on this corridor.